Roche Buys Diagnostic Test Maker IQuum for $275 Million Plus Incentives

Roche April 7 said it had purchased diagnostic test manufacturer IQuum Inc. for $275 million upfront and up to $175 million in contingent product-related milestones.

According to Roche, IQuum’s focus is developing point-of-care offerings for the molecular diagnostics market. The acquisition will give Roche access to IQuum’s Laboratory-in-a-tube (Liat) System, which enables health-care workers to perform rapid molecular diagnostic testing in a point-of-care setting, closer to patients and with minimal training.

The Liat Analyzer and Liat Influenza A/B Assay are CE marked in Europe and cleared by the Food and Drug Administration in the U.S., Roche said.

IQuum is based ...